Spot gold fell nearly $20 in the short term, hitting a new intraday low at $3,979.09 per ounce, down about 0.7%. The decline was driven by persistently high expectations of Federal Reserve rate hikes and a rebound in the US dollar index, which is currently up 0.13% to around 101.30.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bayan Resources and its subsidiaries declare force majeure on coal supply agreements
MoffettNathanson raises SpaceX target price to $142
Survival Nearly Doubles! BioNTech (BNTX.US) Lung Cancer Candidate Drug PRESERVE-003 Achieves Success in Late-Stage Trial, Providing Critical Support for Oncology Transformation
BioNTech (BNTX.US) announced on Monday that a late-stage clinical trial demonstrated its candidate drug gotistobart provided a clinically meaningful overall survival benefit compared to standard therapy in a specific type of lung cancer.

